slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 96,741
Current window 84,271-84,300
Pages 3,225
Rows per page 30
Component
84,271-84,300 of 96,741
54
The slide highlights a 7% decline in combined WELLBUTRIN/APLENZIN revenue.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
64
Includes footnotes regarding non-GAAP adjustments and corporate allocation exclusions.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
66
The slide contains two distinct tables: one for Revenue and one for EBITA (non-GAAP).Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
07
The slide uses a hub-and-spoke style diagram to show how integrated capabilities feed into the pipeline.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
08
The slide uses a comparison structure to contrast two primary therapeutic areas.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
11
Slide 11 from a BioNTech presentation.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
13
Includes immunobridging data and efficacy summary across age groups.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
20
Includes a process flow diagram illustrating the current standard of care and patient outcomes.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
21
BioNTech | Results Presentation Deck | 40 slidesBioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
27
The slide highlights immune activation markers and clinical disease control correlations, setting the stage for a Phase 2 trial.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
08
The slide uses a chronological progression (Prior State, Current State, Planned Future State) to demonstrate growth in product variety.Blue Apron | Investor Presentation Deck | 10 slides · Blue Apron
Pitch deck Investor relations Beat · RoadmapLoop · Why Now1 hit
25
The slide uses a 'Current vs Future' state comparison to illustrate scalability.Boxed | SPAC Presentation Deck | 53 slides · Boxed
Pitch deck Investment bank 1 hit
38
The slide uses a horizontal line to visually anchor the company's valuation against the peer group.Boxed | SPAC Presentation Deck | 53 slides · Boxed
Pitch deck Investment bank 1 hit
39
The slide uses bar charts to compare Boxed against industry peers in three segments.Boxed | SPAC Presentation Deck | 53 slides · Boxed
Pitch deck Investment bank 1 hit
12
The chart uses a waterfall bridge to show the transition from $650M to $751M, with a sub-calculation for organic growth.Broadridge Financial Solutions | Results Presentation Deck | 27 slides · Broadridge
Conference presentation Investor relations Beat · Growth PotentialLoop · Cost Of Inaction1 hit
07
The slide uses a donut chart to illustrate market segmentation of Medicare Advantage enrollees.Cano Health | Investor Presentation Deck | 22 slides · Cano Health
Pitch deck Investor relations Beat · Solution1 hit
12
The slide uses a comparative bar chart structure to highlight performance improvements.Cano Health | Investor Presentation Deck | 22 slides · Cano Health
Pitch deck Investor relations Beat · Traction1 hit
14
The chart shows a clear downward trend in medical claims expense ratio from 73% for new members (<6 months) to 40% for long-term members (>36 months).Cano Health | Investor Presentation Deck | 22 slides · Cano Health
Pitch deck Investor relations Beat · Traction1 hit
17
The slide uses a 4-column layout to map strategic goals to specific performance metrics.Cano Health | Investor Presentation Deck | 22 slides · Cano Health
Pitch deck Investor relations 1 hit
18
Includes a footer with non-GAAP financial measure disclosures.Cano Health | Investor Presentation Deck | 22 slides · Cano Health
Pitch deck Investor relations 1 hit
04
The slide uses a grid layout to present key performance indicators and strategic updates.Cano Health | Results Presentation Deck | 26 slides · Cano Health
Conference presentation Investor relations Beat · Problem1 hit
06
Cano Health | Results Presentation Deck | 26 slidesCano Health | Results Presentation Deck | 26 slides · Cano Health
Conference presentation Investor relations Beat · Financials1 hit
07
The chart tracks the trend of admissions over time, specifically calling out the pandemic peak, a previous update point, and the current status.Cano Health | Results Presentation Deck | 26 slides · Cano Health
Conference presentation Investor relations Beat · Financials1 hit
08
The chart uses a dual-axis approach to show the correlation between total admissions and COVID-19 admissions over time.Cano Health | Results Presentation Deck | 26 slides · Cano Health
Conference presentation Investor relations Beat · FinancialsLoop · Before After1 hit
10
Uses a before-after framing to highlight the reduction in medical costs over time.Cano Health | Results Presentation Deck | 26 slides · Cano Health
Conference presentation Investor relations Beat · FinancialsLoop · Before After1 hit
12
The slide highlights the dual-engine growth strategy of organic expansion and acquisitions.Cano Health | Results Presentation Deck | 26 slides · Cano Health
Conference presentation Investor relations Beat · Financials1 hit
22
BICR = Blinded Independent Central Review; RANO-HGG/LGG = Response Assessment in Neuro-Oncology criteria for High/Low Grade Glioma.Chimerix | Investor Conference Presentation Deck | 32 slides · Chimerix
Conference presentation Investor relations Beat · Solution1 hit
30
The slide compares two different RANO criteria (HGG vs LGG) for the same patient cohort to demonstrate clinical response.Chimerix | Investor Conference Presentation Deck | 32 slides · Chimerix
Conference presentation Investor relations Beat · Solution1 hit
06
The slide uses a comparison table to frame the market opportunity and validate the company's strategic differentiation.Clover Health | Investor Presentation Deck | 28 slides · Clover Health
Pitch deck Investor relations Beat · Market Size1 hit
08
Uses a two-part chart structure to show total market growth vs. competitive share gain.Clover Health | Investor Presentation Deck | 28 slides · Clover Health
Pitch deck Investor relations Beat · Traction1 hit